Barclays Lowers Price Target for Ryan Specialty Stock to $45

Ryan Specialty (NYSE: RYAN) saw its price target reduced from $52.00 to $45.00 by analysts at Barclays in a report released on February 21, 2024. The firm maintains an “overweight” rating on the stock, suggesting that despite the revised target, they see potential value in the company. The new price target indicates a potential upside of approximately 24.29% from the stock’s previous closing price.

Several other research firms have also adjusted their outlook on Ryan Specialty. Piper Sandler recently lowered its price objective from $58.00 to $43.00, assigning a “neutral” rating in a note dated February 13. On February 25, BMO Capital Markets downgraded Ryan Specialty from an “outperform” to a “market perform” rating, cutting their target price from $66.00 to $43.00. Mizuho followed suit, reducing their target from $53.00 to $44.00 while maintaining a “neutral” rating. Additionally, Wells Fargo & Company decreased their price target from $63.00 to $56.00, keeping an “overweight” rating on the stock.

The consensus among analysts shows varied perspectives, with one investment analyst assigning a Strong Buy rating, eight giving a Buy rating, five rating it as Hold, and three issuing a Sell rating. According to data from MarketBeat.com, Ryan Specialty currently holds an average rating of “Hold” with a consensus target price of $56.40.

Stock Performance Overview

On February 21, 2024, Ryan Specialty’s stock opened at $36.21. The company’s 50-day moving average stands at $44.96, while the 200-day moving average is $51.35. Over the past year, the stock has fluctuated significantly, with a 12-month low of $35.84 and a high of $77.16. Ryan Specialty has a market capitalization of $9.56 billion and a price-to-earnings (P/E) ratio of 86.20. The firm also reports a P/E/G ratio of 0.95, indicating growth potential relative to earnings.

In its latest earnings announcement on February 12, Ryan Specialty reported earnings per share (EPS) of $0.45 for the quarter, falling short of the consensus estimate of $0.50 by $0.05. The company’s revenue for the quarter reached $751.21 million, compared to the expected $777.43 million. Despite this miss, Ryan Specialty’s revenue grew by 13.2% from the same quarter last year. Analysts project that the company will post an EPS of 2.29 for the current fiscal year.

Insider Transactions and Institutional Holdings

In related news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the company’s stock on February 23, 2024, at an average price of $39.96 per share, totaling approximately $1.019 million. Following this transaction, Ryan, Jr. now owns 428,295 shares, valued at around $17.11 million, marking a 6.33% increase in his holdings. This acquisition was formally disclosed in a filing with the Securities and Exchange Commission.

Institutional investors hold a significant portion of Ryan Specialty’s stock, with 84.82% of shares owned by such entities. Recent transactions include Los Angeles Capital Management LLC purchasing a new stake valued at $25,000 in the fourth quarter of 2023. Advisory Services Network LLC and SBI Securities Co. Ltd. also acquired new positions, with SBI increasing its stake by a staggering 6,322.2%.

Ryan Specialty Group, Inc. operates as a global specialty insurance and reinsurance platform. The company collaborates with a network of insurers and reinsurers to provide tailored risk solutions across various sectors. Its offerings include specialty lines such as casualty, property, professional liability, marine, energy, and program administration.

Overall, the adjustments in price targets and ratings from various financial institutions reflect a cautious but watchful stance on Ryan Specialty’s stock as it navigates current market conditions and performance outcomes.